EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 8-May-2025 05:09 ET (8-May-2025 09:09 GMT/UTC)

Transforming thymic carcinoma treatment with a dual approach

Juntendo University Research Promotion Center
Peer-Reviewed Publication

Thymic carcinoma, a rare cancer, is often associated with poor prognosis in advanced or recurrent stages. However, its rarity has delayed the development of novel pharmacotherapy. Now, researchers from Japan have evaluated the efficacy and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma. The findings revealed that this combination exhibited a manageable safety profile and may redefine treatment strategies, offering new hope for patients with recurrent thymic cancer.

Journal: The Lancet Oncology

Targeted alpha therapy: a breakthrough in treating refractory skin cancer

Chiba University
Peer-Reviewed Publication

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers from Japan recently developed a new radioactive drug that emits alpha particles. With their short range of emission and high energy, alpha particles are particularly promising for targeted therapies that require high energy release in the cancer tissue while minimizing the damage to nearby healthy tissues.

Journal: European Journal of Nuclear Medicine and Molecular Imaging
Funder: Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, JSPS Grant-in-Aid for Scientific Research on Innovative Areas

Crosstalk among aging, circadian rhythms, and cancers

Research
Peer-Reviewed Publication

A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery and Interventional Science at University College London has systematically summarized the interactions between aging, biological rhythms, and cancer. Their work reveals the underlying mechanisms and clinical applications in tumor biology. The findings were published in the journal of Research entitled "The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies" (Research, 2025, DOI: 10.34133/research.0612).

Journal: Research
Funder: Chinese Scholarship Council, A regional innovation cooperation project of Sichuan Province

Novel radiotracer identifies biomarker for triple-negative breast cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC). According to research published in the March issue of The Journal of Nuclear Medicine, the PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of this aggressive disease, improving clinical outcomes for patients.

Journal: Journal of Nuclear Medicine

Integrating stopping smoking support into talking therapies helps more people quit – new study

University of Bath
Peer-Reviewed Publication

Integrating smoking cessation support into NHS Talking Therapies significantly boosts the chances of patients quitting smoking, particularly those suffering from depression and anxiety.

Journal: Addiction

Breast cancer death rates will rise in elderly EU patients but fall for all other ages

European Society for Medical Oncology
Peer-Reviewed Publication

Experts predict that death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall mortality rates from the disease are predicted to rise by nearly 10% in 2025. However, in the UK, breast cancer death rates are expected to decrease by 7% in this age group, compared to rates observed between 2015-2019. In Spain, there is also a 4% decrease in patients aged 80 and over. These findings are from a new study published in the leading cancer journal Annals of Oncology that predicts death rates from all cancers for 2025 in the EU and UK.

Journal: Annals of Oncology
Funder: Associazione Italiana per la Ricerca sul Cancro, Next Generation EU-MUR PNRR Extended Partnership initiative

New study in the Lancet HIV highlights gaps in HPV-related cancer prevention for people living with HIV

Estonian Research Council
Peer-Reviewed Publication

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities. A literature review, conducted by a team of international experts underscores the need for further research and highlights existing disparities in healthcare for this vulnerable population.

Journal: The Lancet HIV

Scientists create a type of catalog, the ‘colocatome,’ of non-cancerous cells’ influence on cancer

Stanford Medicine
Peer-Reviewed Publication

Stanford Medicine scientists are using artificial intelligence to better capture how healthy cells surrounding tumors influence cancer cell behavior and how those interactions can inform treatments.

Journal: Nature Communications

Hibernating lemurs can turn back the clock on cellular aging

Duke University
Peer-Reviewed Publication

We’re all familiar with the outward signs of aging, such as sagging skin or thinning hair. But many age-related changes start within our cells, even our DNA, which can wear and tear over time. One creature has a way to reverse this process, at least temporarily. A hamster-sized primate from Madagascar, the fat-tailed dwarf lemur can turn back the aging clock during its annual hibernation season, according to markers of cellular aging called telomeres.

Journal: Biology Letters
Funder: Duke Lemur Center

Long visit in the ER? It’s a good time to learn about cervical cancer screening

University of Rochester Medical Center
Peer-Reviewed Publication

Researchers were able to double the number of screenings with an innovative clinical trial.

Journal: Academic Emergency Medicine
Funder: NIH/National Cancer Institute

66
67
68
69
70